As part of this partnership, Fasken will provide educational insights to emerging actors in the life sciences industry. This partnership is part of a common desire to support businesses in the biomedical technologies (medtech) sector. Fasken’s implication in various program initiatives will allow startups and innovative companies in the medtech sector to benefit from strategic and legal thought leadership to help accelerate the launch of their technologies. Learn more

Montréal, Canada – October 8, 2025 – Glycovax Pharma today announced a strategic collaboration with the National Research Council of...